North America Influenza Market Competitive landscape analysis
North America Influenza Market is expected to reach USD 4.59 billion by 2021 from USD 2.99 billion in 2016, growing at a CAGR of 8.97% during the forecast period, 2016-2021.
(EMAILWIRE.COM, September 15, 2017 ) Influenza or flu is a transmittable respiratory disease which affect nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be either seasonal, pandemic, or zoonotic. Influenza market can be fatal if goes unnoticed and is regarded as a major reason of mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. As per Centers for Disease Control and Prevention (CDC), 5% to 20% of U.S. population are infected with flu, annually. Also, as per Public Health Agency of Canada, approximately 5,365 people were hospitalized due to influenza in 2015-2016. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-influenza-market-1705/
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, boost in healthcare expenditure, and introduction of new medicines, and. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, and side-effects of product (soreness, allergic reactions, swelling, and redness).
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-influenza-market-1705/request-sample
The North America Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-influenza-market-1705/inquire
The North America market is geographically segmented into United States and Canada.
The major companies dominating the North America Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-influenza-market-1705/
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, boost in healthcare expenditure, and introduction of new medicines, and. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, and side-effects of product (soreness, allergic reactions, swelling, and redness).
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-influenza-market-1705/request-sample
The North America Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-influenza-market-1705/inquire
The North America market is geographically segmented into United States and Canada.
The major companies dominating the North America Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results